Evaluation of the pilot program on the real-time drug utilization review system in South Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Heo, Ji Haeng | - |
dc.contributor.author | Suh, Dong Churl | - |
dc.contributor.author | Kim, Sukil | - |
dc.contributor.author | Lee, Eui-Kyung | - |
dc.date.available | 2019-03-09T01:02:28Z | - |
dc.date.issued | 2013-10 | - |
dc.identifier.issn | 1386-5056 | - |
dc.identifier.issn | 1872-8243 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/14243 | - |
dc.description.abstract | Purpose: A pilot drug utilization review (DUR) program was initiated by the Korean government, which provided safety information in real-time at the stage of prescribing and dispensing. This study aimed to compare the "physician/pharmacist Co-DUR" system and the traditional "pharmacist-only DUR" system. Methods: Data collected during a DUR pilot program from July 1 to October 31 of 2009 were obtained from the Health Insurance Review & Assessment Service. Descriptive analyses were conducted to investigate DUR-pop up alert rates, categories of alerts, the reasons for dispensing without prescription change after an alert, and changes in drug expenditures associated with the DUR. Results: DUR pop-up alert rates were 8.55% at clinics and 1.90% at pharmacies in the physician/pharmacist Co-DUR, whereas the rate was 2.22% in the pharmacist-only DUR. Rates of pop-up alerts were high for between-prescription ingredient duplication at pharmacies, whereas for clinics, the rate for drug-pregnancy contraindications was high. A greater reduction in drug expenditure was estimated in the physician/pharmacist Co-DUR compared to the pharmacist-only DUR. Conclusions: The physician/pharmacist Co-DUR has better sensitivity at detecting potential adverse drug events than the pharmacist-only DUR. Pharmacists also have opportunities to double-check prescribed drugs when doctors do not voluntarily modify pop-up alerts. Further comprehensive study will be needed to confirm the results of pilot program that favored the physician/pharmacist Co-DUR. (C) 2013 Published by Elsevier Ireland Ltd. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ELSEVIER IRELAND LTD | - |
dc.title | Evaluation of the pilot program on the real-time drug utilization review system in South Korea | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.ijmedinf.2013.07.001 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, v.82, no.10, pp 987 - 995 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000324312000009 | - |
dc.identifier.scopusid | 2-s2.0-84887406483 | - |
dc.citation.endPage | 995 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 987 | - |
dc.citation.title | INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS | - |
dc.citation.volume | 82 | - |
dc.type.docType | Review | - |
dc.publisher.location | 아일랜드 | - |
dc.subject.keywordAuthor | Drug utilization review | - |
dc.subject.keywordAuthor | Inappropriate prescribing | - |
dc.subject.keywordAuthor | Real-time system | - |
dc.subject.keywordAuthor | Expenditures | - |
dc.subject.keywordPlus | POLYPHARMACY | - |
dc.relation.journalResearchArea | Computer Science | - |
dc.relation.journalResearchArea | Health Care Sciences & Services | - |
dc.relation.journalResearchArea | Medical Informatics | - |
dc.relation.journalWebOfScienceCategory | Computer Science, Information Systems | - |
dc.relation.journalWebOfScienceCategory | Health Care Sciences & Services | - |
dc.relation.journalWebOfScienceCategory | Medical Informatics | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.